The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
The relatives of people who died after being given blood infected with HIV and hepatitis can now apply for interim ...
Uganda's efforts to combat the HIV/AIDS epidemic have made significant strides, yet crucial gaps remain, particularly in preventing mother-to-child transmission of the virus.
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
The South African National Aids Council is meant to play a co-ordinating role in the country’s response to HIV, bringing ...
GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
The Executive Director of UNAIDS Winnie Byanyima is calling for accelerated global solidarity to strengthen Madagascar's response to HIV, including preventing new HIV infections and expanding access ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback